Zenarestat
Zenarestat is an orally bioavailable aldose reductase inhibitor used in research. It has demonstrated efficacy in ameliorating symptoms of diabetic peripheral neuropathy in rodent models of type 2 diabetes, supporting investigations into the polyol pathway's role in diabetic complications.
Product Specifications
CAS Number
112733-06-9
Product Name Alternative
FK 366, FK366, FK-366, FR 74366, FR74366, FR-74366, CI 1014, CI1014, CI-1014, Zenarestat
Field of Research
Metabolism Research
Purity
99.51% (May vary between batches)
Solubility
DMSO:80 mg/mL (181.14 mM)
Smiles
O=C (O) CN1C (=O) N (C (=O) C2=CC=C (Cl) C=C21) CC3=CC=C (Br) C=C3F
Molecular Formula
C17H11BrClFN2O4
Molecular Weight
441.64
Storage Conditions
-20°C
Notes
For research use only.
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1611449-01 48 Well
Human Tyrosine-protein kinase RYK, RYK ELISA Kit
Sign In for Pricing
View Details 
MBS1611449-02 96 Well
Human Tyrosine-protein kinase RYK, RYK ELISA Kit
Sign In for Pricing
View Details MBS1611449-03 5x 96 Well
Human Tyrosine-protein kinase RYK, RYK ELISA Kit
Sign In for Pricing
View Details MBS1611449-04 10x 96 Well
Human Tyrosine-protein kinase RYK, RYK ELISA Kit
Sign In for Pricing
View Details 
OAAF05755-100UG-FITC 100 µg
FucT-IV Antibody : FITC (OAAF05755-FITC)
Sign In for Pricing
View Details 